Inhibition by heparin of platelet activation induced by neutrophil-derived cathepsin G
- 1 June 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 216 (3) , 401-405
- https://doi.org/10.1016/0014-2999(92)90437-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinasesBlood, 1991
- Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin GAmerican Journal of Physiology-Cell Physiology, 1990
- Impaired filterability of white cells in acute cerebral infarction.BMJ, 1989
- Neutrophil function in ischemic heart disease.Circulation, 1989
- Abnormal flow properties of white blood cells in patients with severe ischaemia of the legBMJ, 1988
- Inhibition of leucocyte elastase by heparin and its derivativesBiochemical Journal, 1988
- Leukocytes and the risk of ischemic diseasesPublished by American Medical Association (AMA) ,1987
- Antithrombotic and bleeding effects of a low molecular weight heparin fractionBiochemical Pharmacology, 1985
- Interaction of the chymotrypsin- and elastase-like enzymes of the human granulocyte with glycosaminoglycansBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- The molecular-weight range of mucosal-heparin preparationsCarbohydrate Research, 1976